ClinicalTrials.gov record
Completed No phase listed Observational Results available

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

ClinicalTrials.gov ID: NCT05510908

Public ClinicalTrials.gov record NCT05510908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AIDS Malignancy Consortium A Trial of the AIDS Malignancy Consortium (AMC)

Study identification

NCT ID
NCT05510908
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AIDS Malignancy Consortium
Network
Enrollment
460 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2023
Primary completion
Feb 27, 2025
Completion
Jun 1, 2025
Last update posted
Mar 24, 2026

2023 – 2025

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Moores UCSD Cancer Center La Jolla California 92903
George Washington University Cancer Center Washington D.C. District of Columbia 20037
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136
Moffitt Cancer Center Tampa Florida 33612
University of Illinois at Chicago Chicago Illinois 60612
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231
Washington University School of Medicine St Louis Missouri 63110
Weill Cornell Medicine - Cornell Clinical Trials Unit New York New York 10010
Mount Sinai Hospital New York New York 10029
Montefiore Medical Center The Bronx New York 10467
The Ohio State University Columbus Ohio 43210
Abramson Cancer Center at Pennsylvania Hospital Philadelphia Pennsylvania 19106
MD Anderson Cancer Center Houston Texas 77030
Huntsman Cancer Institute - University of Utah Salt Lake City Utah 84112
Virginia Mason Medical Center Seattle Washington 98101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05510908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05510908 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →